XML 71 R55.htm IDEA: XBRL DOCUMENT v3.6.0.2
Commitments and Contingencies - Additional Information (Detail)
12 Months Ended
Jun. 30, 2015
ft²
Jan. 31, 2015
ft²
Apr. 30, 2014
ft²
Jan. 31, 2014
ft²
May 08, 2013
ft²
Dec. 15, 2012
ft²
Dec. 06, 2011
ft²
Dec. 31, 2016
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2016
GBP (£)
Dec. 15, 2016
ft²
Nov. 01, 2013
USD ($)
ft²
Nov. 01, 2013
EUR (€)
ft²
Sep. 30, 2011
ft²
Jul. 01, 2011
ft²
Commitments and Contingencies Disclosure [Line Items]                                
Operating lease, rental expense | $               $ 600,000 $ 800,000 $ 1,000,000            
Potential payable amount over the agreement terms based on minimum purchase obligation | $               $ 44,600,000                
Dublin                                
Commitments and Contingencies Disclosure [Line Items]                                
Office space leased (in square feet)                         270 270 320  
Operating lease, expiration date               Oct. 31, 2017                
Operating lease, renewal option               1 year                
Operating lease, monthly rent                         $ 3,100 € 2,900    
Bedminster                                
Commitments and Contingencies Disclosure [Line Items]                                
Office space leased (in square feet)                       732       9,747
Operating lease, expiration date               Mar. 31, 2018                
Additional office space leased (in square feet)         10,883 2,601 2,142                  
Square feet vacated in exchange for reduction on future rent payments     2,000 2,142                        
Sublease | Bedminster                                
Commitments and Contingencies Disclosure [Line Items]                                
Additional office space leased under sublease (in square feet) 2,500 4,700                            
Further Indication for AMR101 | Marketing Approval In Europe                                
Commitments and Contingencies Disclosure [Line Items]                                
Potential aggregate stock or cash payment               $ 9,300,000     £ 7,500,000          
Further Indication for AMR101 | Potential Marketing Approval 1                                
Commitments and Contingencies Disclosure [Line Items]                                
Potential aggregate stock or cash payment               6,200,000     5,000,000          
Further Indication for AMR101 | Potential Marketing Approval 2                                
Commitments and Contingencies Disclosure [Line Items]                                
Potential aggregate stock or cash payment               6,200,000     5,000,000          
Further Indication for AMR101 | Maximum                                
Commitments and Contingencies Disclosure [Line Items]                                
Potential aggregate stock or cash payment               $ 12,300,000     £ 10,000,000